• 23andMe Caps a Year of Recovery with a $115 Million Funding Round

    Forbes | With a drug discovery business, an FDA-cleared test, and a new valuation at over $1 billions, 23andMe is once again on the upswing, writes Matthew Herper.

    Oct 14, 2015

  • The Social Face of Genetics at the American Society of Human Genetics Meeting

    Bio-IT World | The annual meeting of the ASHG convened last week in Baltimore, in the midst of a new Precision Medicine Initiative that aims to collect one million patients' genomes and medical records into a national cohort. As NIH Director Francis Collins spoke about the possibilities and social responsibilities of that project, ASHG President Neil Risch reflected on past and ongoing misuses of genetics, and a panel of science journalists considered how scientists can best engage the public, build trust, and help non-professionals wrangle with the real-world implications of new discoveries.

    Oct 14, 2015

  • Elizabeth Parrish CEO of BioViva Claims to Undergo Anti-Aging Therapy

    MIT Technology Review | An American woman claims she is the first to undergo gene therapy to reverse aging. Judge for yourself.

    Oct 14, 2015

  • New Products and Announcements at the American Society of Human Genetics Meeting

    Bio-IT World | Companies including Illumina, Complete Genomics, Pacific Biosciences, Invitae, QIAGEN, and DNAnexus gathered this week at the annual meeting of the American Society of Human Genetics in Baltimore to show off their latest products and services.

    Oct 9, 2015

  • Amazon wants companies to get onto its cloud using new services

    Computerworld | Amazon launched a handful of new services all aimed at getting companies onto its cloud platform Wednesday, including a new ruggedized box for shipping data to the cloud provider.

    Oct 9, 2015

  • Estonia Is Embracing Personalized Medicine With Its DNA Biobank

    The Atlantic | The country's genetic biobank is still in its earliest stages, but the government hopes to one day have enough donors to totally overhaul its health-care system.

    Oct 9, 2015

  • GENALICE Launches Population Calling Analysis Module

    Bio-IT World In a live webinar today, GENALICE launched the Population Calling analysis module to their GENALICE MAP Next-Generation Sequencing (NGS) Data Analysis Suite. In partnership with Mount Sinai Hospital, Amazon Web Services, and Intel, GENALICE processed the whole genomes of 800 patients from the Alzheimer’s Disease Neuroimaging Initiative (ADNI), an Alzheimer’s disease cohort during the webinar.

    Oct 8, 2015

  • GSK Updates on Social Media Tracking

    MobiHealthNews | GlaxoSmithKline and Epidemico won a 2015 Bio-IT World Best Practices award last year for ProjectCRAWL, an effort to survey social media to alert GSK to adverse events. Yesterday, GSK's director of pharmacovigilance gave an update on how the pharma is using Epidemico's data.

    Oct 6, 2015

  • With Cleversafe buy IBM zeroes in on unstructured data

    Computerworld | IBM will acquire object-based storage vendor Cleversafe in a move to bolster its cloud business unit with more flexibility and simplified management options in the hybrid cloud, it announced on Monday.

    Oct 5, 2015

  • Can the New Google Have a Long and Productive Life?

    MIT Technology Review | To truly change the world, Google's new holding company will need something that has eluded many previous industrial labs: an effective commercialization strategy.

    Oct 2, 2015

  • A Worthy Sequel: PacBio's New Sequencing System

    Bio-IT World | Pacific Biosciences has released a new genome sequencing instrument, the Sequel — providing the first-in-class whole genome assemblies of its predecessor the RS II, but much faster and at half the cost. But the company's underlying problems, pitching high quality in a price-sensitive market, are not much changed.

    Oct 1, 2015

  • With $55M Neon Wants To Make the Cancer Vaccine Problem Personal

    Xconomy | Neon Therapeutics hopes to harness the body's immune system against the genetic fingerprints of tumors, creating a new kind of cancer vaccine.

    Oct 1, 2015

  • September News and Product Briefs

    Bio-IT World | News and product releases from around the industry, including results from a study on Apple's ResearchKit, and population-scale genome analytics from GENALICE.

    Sep 30, 2015

  • How People Living at Earth's Extremes Reveal the Genome's Best Tricks

    The Atlantic | Evolution has sculpted the human genome to cope with Earth's toughest climates, inadvertently pointing geneticists towards medically important genes.

    Sep 30, 2015

  • Speed Heals: The 26-Hour Diagnostic Genome

    Bio-IT World | Stephen Kingsmore and his colleagues at the Center for Pediatric Genomic Medicine at Children’s Mercy in Kansas City, announced 26-hour diagnostic whole genome sequencing in a paper published today in Genomic Medicine, an improvement over the 50-hour whole genome sequencing the group published in 2012. The paper is published just one day after Kingsmore took his new post as President and CEO of the Rady Pediatric Genomics and Systems Medicine Institute at Rady Children’s Hospital in San Diego.

    Sep 29, 2015

  • Drug Pricing Fears Erase Biotech Stock Gains for the Year

    The Street | Anger over a price hike at Turing Pharmaceuticals and a Congressional letter to Valeant have dealt a blow to biotech stocks that many observers already fretted were sharply overvalued.

    Sep 29, 2015

  • Tour of the Cloud: Emerald Cloud Labs’ Hardware and Software Vision

    Bio-IT World | Emerald Cloud Labs' robotics facility for programmable scientific experiments is up and running in South San Francisco, as Bio-IT World editor Allison Proffitt reports from inside the lab.

    Sep 24, 2015

  • FDA Turns Its Eye on Pathway's 'Direct-to-Consumer' Cancer Test

    Diagnostics World | This Thursday, the FDA sent a letter to Pathway Genomics warning the company that a newly introduced test, a liquid biopsy to find early-stage cancer in apparently healthy people, has not been clinically validated and could be harmful to public health. The letter not only calls attention to the shaky evidence for this test's accuracy, but also asserts the FDA's authority over a whole category of tests in a regulatory gray area.

    Sep 25, 2015

  • Farewell Nabsys

    Omics! Omics! Blog | Nabsys and its all-electronic single molecule physical mapping approach closed its doors a little over a week ago.

    Sep 25, 2015

  • Bring your companys dark data to light with this free new tool from Tamr

    Computerworld | Tamr's enterprise metadata catalog can help companies create an inventory of their data sources, including metadata about who owns the source.

    Sep 24, 2015